FR2368281A1 - Nouvelle culture cellulaire, son application a la preparation d'un vaccin antiviral et vaccin obtenu - Google Patents

Nouvelle culture cellulaire, son application a la preparation d'un vaccin antiviral et vaccin obtenu

Info

Publication number
FR2368281A1
FR2368281A1 FR7612334A FR7612334A FR2368281A1 FR 2368281 A1 FR2368281 A1 FR 2368281A1 FR 7612334 A FR7612334 A FR 7612334A FR 7612334 A FR7612334 A FR 7612334A FR 2368281 A1 FR2368281 A1 FR 2368281A1
Authority
FR
France
Prior art keywords
vaccine
cell culture
new cell
preparation
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7612334A
Other languages
English (en)
French (fr)
Other versions
FR2368281B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cutter Laboratories Inc filed Critical Cutter Laboratories Inc
Priority to FR7612334A priority Critical patent/FR2368281A1/fr
Publication of FR2368281A1 publication Critical patent/FR2368281A1/fr
Application granted granted Critical
Publication of FR2368281B1 publication Critical patent/FR2368281B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12111—Orbivirus, e.g. bluetongue virus
    • C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7612334A 1976-04-26 1976-04-26 Nouvelle culture cellulaire, son application a la preparation d'un vaccin antiviral et vaccin obtenu Granted FR2368281A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7612334A FR2368281A1 (fr) 1976-04-26 1976-04-26 Nouvelle culture cellulaire, son application a la preparation d'un vaccin antiviral et vaccin obtenu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7612334A FR2368281A1 (fr) 1976-04-26 1976-04-26 Nouvelle culture cellulaire, son application a la preparation d'un vaccin antiviral et vaccin obtenu

Publications (2)

Publication Number Publication Date
FR2368281A1 true FR2368281A1 (fr) 1978-05-19
FR2368281B1 FR2368281B1 (enExample) 1979-03-02

Family

ID=9172325

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7612334A Granted FR2368281A1 (fr) 1976-04-26 1976-04-26 Nouvelle culture cellulaire, son application a la preparation d'un vaccin antiviral et vaccin obtenu

Country Status (1)

Country Link
FR (1) FR2368281A1 (enExample)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1484638A (fr) * 1965-11-17 1967-06-16 Rhone Poulenc Sa Procédé de culture et d'inactivation d'un nouveau virus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1484638A (fr) * 1965-11-17 1967-06-16 Rhone Poulenc Sa Procédé de culture et d'inactivation d'un nouveau virus

Also Published As

Publication number Publication date
FR2368281B1 (enExample) 1979-03-02

Similar Documents

Publication Publication Date Title
NO981374D0 (no) Dendrittcellestimulerende faktor
ES422961A1 (es) Procedimiento para preparar una suspension de virus.
ES2098029T3 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
ES2033871T3 (es) Un procedimiento para producir una preparacion de insulina para administracion parenteral.
ES8602112A1 (es) Procedimiento para preparar un polipeptido ciclico
SE7700066L (sv) Forfarande for framstellning av enzym-preparat med l-alfa-aminoacylamidasaktivitet
ATE15693T1 (de) Zellkultur-verfahren.
DK232483D0 (da) Fremgangsmade til fremstilling af ws 6049-forbindelser
YU391A (sh) Biomasa za proizvodnju virusa/virusantigena
GB1413667A (en) Propelling devices
DE69028320D1 (de) Illudin-analoge, verwendet als antitumormittel
DK363088D0 (da) Dobbeltstrenget rna-korrektion af afvigende metaboliske baner, der staar i forbindelse med ukontrollerede tumorcelle- og virusvaekstcykler
FR2368281A1 (fr) Nouvelle culture cellulaire, son application a la preparation d'un vaccin antiviral et vaccin obtenu
ES8202059A1 (es) Un metodo de preparacion de antigeno superficial de la hepa-titis b
GB1508878A (en) Hepatitis a antigen
GB1108287A (en) Improvements in or relating to the preparation of a milk-coagulating enzyme
ES2000435A4 (es) Procedimiento de purificacion de antigenos proteinicos de bacterias que pertenecen al genero bordetella, en vista a la obtencion de una vacuna acelular.
IT7922818A0 (it) Procedimento per mantenere attiva la cultura di fermenti.
ES2053623T3 (es) Procedimiento para la preparacion de enzimas fijadas a un soporte.
Kańtoch Markers and vaccines
SE8205247D0 (sv) Fiskvacciner
GB1303579A (enExample)
SU705564A1 (ru) Способ подачи паров рабочего тела
GB1108956A (en) Process for the manufacture of bcg vaccines
GB1091595A (en) Brucella vaccines

Legal Events

Date Code Title Description
ST Notification of lapse